Phellodendron (Amur Cork Tree Bark)
Also called Phellodendron amurense, Amur cork tree, Phellodendri cortex, phellodendron bark, NP 06-1.
Best grade D across 5 graded outcomes Botanical Last checked
We earn a commission if you buy through links on this page. It never changes our grades or rankings. How we make money →
The short answer
From 9 sourcesPhellodendron bark reaches supplements almost only in blends, mainly Relora with magnolia bark. Four small trials, all sponsored by blend maker Next Pharmaceuticals, report less temporary anxiety, lower cortisol or better knee scores. Phellodendron alone has been studied only for tolerance, in 21 men with prostate cancer. No federal or regulatory agency has reviewed its safety.
Every graded outcome on this page
5 rows · line = participants- DGrade DSalivary cortisol and mood in moderately stressed adultsStressn 56
- DGrade DKnee osteoarthritis pain and function (Lequesne index)Jointsn 45
- DGrade DLipids, blood pressure and weightHeart markersn 45
- DGrade DAnxiety, cortisol and sleep in stressed womenStressn 40
- DGrade DWeight change in stress eatersWeightn 28
Key facts
- What it is
- Bark of Phellodendron amurense, used in traditional Chinese medicine; its bioactive compounds include berberine and palmatine1
- How it is sold
- Mostly in Relora, a proprietary magnolia and phellodendron bark blend, or NP 06-1, a phellodendron bark and sweet orange peel blend25
- Cortisol
- In 56 moderately stressed adults, 4 weeks of Relora lowered salivary cortisol exposure by 18% vs placebo4
- Anxiety
- Relora at 750 mg/day eased temporary (state) anxiety but not trait anxiety, cortisol or sleep in a 6-week pilot (26 of 40 women completed)2
- Agency safety reviews
- No ODS, NCCIH, LactMed, LiverTox, Health Canada or EMA source covers phellodendron7
What it is
Phellodendron amurense bark is a traditional Chinese medicine ingredient containing berberine and palmatine, sold mainly in blends.
Forms, side by side
3 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Phellodendron (Amur Cork Tree Bark) forms compared
3 forms| 3 forms | Magnolia + phellodendron blend (Relora) | Phellodendron + sweet orange peel blend (NP 06-1) | Phellodendron bark extract alone (e.g., Nexrutine) |
|---|---|---|---|
| Absorption in people | No human absorption data in our sources.2 | No human absorption data in our sources.5 | No human absorption data in our sources.1 |
| GI tolerance | No significant adverse events in 6-week trials at 750 mg/day.23 | No serious adverse events over 8 weeks at 1,480 mg/day.5 | In an uncontrolled study of 21 men with prostate cancer, 500 mg three times daily for 1–2 months caused two transient grade 3 side effects (low potassium, urinary incontinence) and no grade 4 events.9 |
| Studied for | Stress, temporary anxiety, cortisol, weight in stress eaters | Knee osteoarthritis scores and cardiovascular markers | Tolerance before prostate cancer surgery or radiation (uncontrolled); no controlled single-ingredient trials |
- Magnolia + phellodendron blend (Relora)
- Absorption in people
- No human absorption data in our sources.2
- Studied for
- Stress, temporary anxiety, cortisol, weight in stress eaters
- Phellodendron + sweet orange peel blend (NP 06-1)
- Phellodendron bark extract alone (e.g., Nexrutine)
- Absorption in people
- No human absorption data in our sources.1
- GI tolerance
- In an uncontrolled study of 21 men with prostate cancer, 500 mg three times daily for 1–2 months caused two transient grade 3 side effects (low potassium, urinary incontinence) and no grade 4 events.9
- Studied for
- Tolerance before prostate cancer surgery or radiation (uncontrolled); no controlled single-ingredient trials
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
5 graded outcomes, largest study first5 graded outcomes: 4 improved, 1 mixed. The largest, a 2013 randomized trial of 56 people on salivary cortisol and mood in moderately stressed adults, found an improvement.
1Salivary cortisol and mood in moderately stressed adults
Improved · Grade D · RCT, 56 people, 2013
Adults screened for moderate stress (35 men, 21 women)
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Salivary cortisol and mood in moderately stressed adults | Improved | 56 | Grade D · RCT, 2013 | Adults screened for moderate stress (35 men, 21 women) |
| Knee osteoarthritis pain and function (Lequesne index) | Improved | 45 | Grade D · Pilot RCT, 2009 | Overweight and normal-weight adults with knee osteoarthritis in 4 groups (80 enrolled, 45 completed) |
| Lipids, blood pressure and weight | Improved | 45 | Grade D · Pilot RCT, 2008 | Same 80 adults with knee osteoarthritis (45 completed) |
| Anxiety, cortisol and sleep in stressed women | Mixed | 40 | Grade D · Pilot RCT, 2008 | Overweight premenopausal women aged 20 to 50 who eat in response to stress (40 intent-to-treat, 26 completed) |
| Weight change in stress eaters | Improved | 28 | Grade D · Pilot RCT, 2006 | Overweight premenopausal women who eat in response to stress (28 completers) |
Every graded row
5 rowsShowing 5 of 5 outcomes. Human trials only.
DGrade DSalivary cortisol and mood in moderately stressed adultsStressCortisol -18%RCT
n 56 · 2013
Improved Salivary cortisol exposure was 18% lower than with placebo; overall stress (-11%), tension, depression, anger, fatigue and confusion scores were lower, and global mood and vigour higher.
- Design
- RCT, n = 56, 2013
- Population
- Adults screened for moderate stress (35 men, 21 women)
- Form
- Relora (magnolia + phellodendron bark blend)
- Dose
- Not stated in the abstract
- Duration
- 4 weeks
- Source
- Reference 4 · PubMed 23924268 (opens PubMed)
DGrade DKnee osteoarthritis pain and function (Lequesne index)JointsImprovedPilot RCT
n 45 · 2009
Improved Lequesne scores improved vs placebo in both weight groups (overweight: 6.3 vs 11.8); CRP fell vs placebo in the overweight group; both treatment groups lost weight (about 5% in the overweight group), which may have contributed.
- Design
- Pilot RCT, n = 45, 2009
- Population
- Overweight and normal-weight adults with knee osteoarthritis in 4 groups (80 enrolled, 45 completed)
- Form
- NP 06-1 (phellodendron bark + sweet orange peel extracts)
- Dose
- Two 370 mg capsules twice daily (1,480 mg/day)
- Duration
- 8 weeks
- Source
- Reference 5 · PubMed 19682376 (opens PubMed)
DGrade DLipids, blood pressure and weightHeart markersImprovedPilot RCT
n 45 · 2008
Improved Triglycerides and LDL fell and HDL rose vs placebo in both weight groups; blood pressure decreased; fasting glucose fell in the overweight group; both treatment groups lost weight.
- Design
- Pilot RCT, n = 45, 2008
- Population
- Same 80 adults with knee osteoarthritis (45 completed)
- Form
- NP 06-1 (phellodendron bark + sweet orange peel extracts)
- Dose
- Two 370 mg capsules twice daily (1,480 mg/day)
- Duration
- 8 weeks
- Source
- Reference 6 · PubMed 18492265 (opens PubMed)
DGrade DAnxiety, cortisol and sleep in stressed womenStressMixedPilot RCT
n 40 · 2008
Mixed State (temporary) anxiety fell vs placebo; trait anxiety, salivary cortisol and amylase, appetite, body measures and sleep quality did not differ. No significant adverse events.
- Design
- Pilot RCT, n = 40, 2008
- Population
- Overweight premenopausal women aged 20 to 50 who eat in response to stress (40 intent-to-treat, 26 completed)
- Form
- Relora (magnolia + phellodendron bark blend)
- Dose
- 250 mg three times daily (750 mg/day)
- Duration
- 6 weeks
- Source
- Reference 2 · PubMed 18426577 (opens PubMed)
DGrade DWeight change in stress eatersWeightImprovedPilot RCT
n 28 · 2006
Improved The placebo group gained an average 1.5 kg while the treatment group did not change; 75% of controls vs 37% on treatment gained 1 kg or more. The cortisol difference was a non-significant trend.
- Design
- Pilot RCT, n = 28, 2006
- Population
- Overweight premenopausal women who eat in response to stress (28 completers)
- Form
- Magnolia + phellodendron bark extracts (Relora)
- Dose
- 250 mg three times daily (750 mg/day)
- Duration
- 6 weeks
- Source
- Reference 3 · PubMed 16454147 (opens PubMed)
Phellodendron alone: a tolerance study
1 noteHuman data outside the graded table.
- Prostate cancer tolerance study (uncontrolled)
- 21 men received Phellodendron amurense bark extract (Nexrutine) 500 mg three times daily for 1–2 months before surgery or with radiation. There were two transient grade 3 side effects and no grade 4 events; PSA fell in 81% by the end of the pre-treatment phase. With no control group, this measures tolerance, not benefit.9
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Doses studied in human trials ranged from 750 mg a day of the magnolia-phellodendron blend Relora for 6 weeks to 1,480 mg a day of a phellodendron-orange peel blend for 8 weeks; the abstracts do not state how much phellodendron the blends contain. No controlled trial gave phellodendron alone; an uncontrolled tolerance study used 500 mg of bark extract three times daily.2359
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Phellodendron meets
1 cited row 5 tested togetherMedicines 1
Supplements and foods 1
- Reference summary
- Tested together in a graded trial
Choose a medicine or supplement above to read its cited rows here.
Also cited: 5 tested together
Warfarin
ReviewReference summary
Warfarin, for example Coumadin, Jantoven: A 2024 review of herb–warfarin interactions reports that Phellodendron amurense competes with warfarin for binding to blood proteins. This can raise the amount of free warfarin in the blood and strengthen its anticoagulant effect.
Source 8, Curr Drug Metab (2024)
Magnolia barkMagnolia bark page
Tested together
Cortisol and mood in moderately stressed adults. Graded on the Magnolia bark page; tested together is not a claim that they work better together.
Tested together
Anxiety, cortisol and sleep. Graded on the Magnolia bark page; tested together is not a claim that they work better together.
Tested together
Salivary cortisol and mood in moderately stressed adults. Graded on the Phellodendron page; tested together is not a claim that they work better together.
Tested together
Anxiety, cortisol and sleep in stressed women. Graded on the Phellodendron page; tested together is not a claim that they work better together.
Tested together
Weight change in stress eaters. Graded on the Phellodendron page; tested together is not a claim that they work better together.
Interactions
1 agent| Agent | What the source says | Evidence |
|---|---|---|
| Medicines1 | ||
| Warfarine.g. Coumadin, Jantoven | A 2024 review of herb–warfarin interactions reports that Phellodendron amurense competes with warfarin for binding to blood proteins. This can raise the amount of free warfarin in the blood and strengthen its anticoagulant effect.8 | Review |
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Phellodendron and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Phellodendron.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
3 groups- People on medicines
- No ODS, NCCIH, LactMed, LiverTox, Health Canada or EMA source covers phellodendron. NCCIH notes that dietary supplements may interact with medications. Phellodendron contains berberine, which has its own page. In a small tolerance study of the extract alone, grade 3 low blood potassium was one of two transient side effects.719
- Pregnancy, breastfeeding and children
- No trial studied these groups, and NCCIH notes that many dietary supplements have not been tested in pregnant women, nursing mothers or children.7
- Before surgery
- NCCIH advises telling your health care providers about all supplements well before an operation.7
How to read the label
What to check on the Supplement Facts panel.
How to read the label
2 checksWhere to buy Phellodendron (Amur Cork Tree Bark)
Products from brands we partner with that contain Phellodendron (Amur Cork Tree Bark). Check the amount per serving against the doses studied above, and the label for other ingredients.
Phellodendron (Amur Cork Tree Bark) products from partner brands
1 product Paid links · we earn a commission- HerbsProNOW Foods Relora, 300 mg, 120 Vcaps
1 veg capsule: 300 mg Relora (proprietary blend of Magnolia officinalis bark extract and Phellodendron amurense bark extract); phellodendron amount not stated
$24.99one-timeChecked Oct 15, 2026
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersWhat is phellodendron used for?
Does Relora lower stress or cortisol?
Does phellodendron help knee osteoarthritis?
One 8-week pilot of a phellodendron-orange peel blend improved knee pain and function scores, but only 45 of 80 people finished, participants also lost weight, and the sponsor made the product.5
Is phellodendron safe?
Is phellodendron safe during pregnancy or breastfeeding?
There are no data. No trial included pregnant or breastfeeding women, no LactMed record exists, and NCCIH notes that many supplements have not been tested in these groups.7
Does phellodendron contain berberine?
Yes. Berberine and palmatine are among the bioactive compounds in Phellodendron bark.1
Sources
9 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
9 sources- 1Protective Effects of Phellodendron Species on Bone Health: A Novel Perspective on Their Potentials in Treating Osteoporosis and Osteoarthritis.Review Chin J Integr Med, 2024 · PMID 38157118
- 2Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial.Pilot RCT Nutr J, 2008 · PMID 18426577
- 3Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.Pilot RCT Altern Ther Health Med, 2006 · PMID 16454147
- 4Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects.RCT J Int Soc Sports Nutr, 2013 · PMID 23924268
- 5Phellodendron and Citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.Pilot RCT Nutr J, 2009 · PMID 19682376
- 6Phellodendron and Citrus extracts benefit cardiovascular health in osteoarthritis patients: a double-blind, placebo-controlled pilot study.Pilot RCT Nutr J, 2008 · PMID 18492265
- 7Using Dietary Supplements WiselyFact sheet National Center for Complementary and Integrative Health (NCCIH), 2019 · nccih.nih.gov
- 8Safety Issues of Herb-Warfarin Interactions.Review Curr Drug Metab, 2024 · PMID 38465436
- 9Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer.Open-label trial Phytother Res, 2015 · PMID 25205619
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| summary, forms, studied doses, research notes, who should be careful, FAQ | Searched PubMed for phellodendron and Relora trials and meta-analyses through 2026; no new controlled trial found. Corrected the claim that phellodendron was never tested alone: added an uncontrolled 21-man tolerance study of Phellodendron amurense bark extract (Nexrutine, PMID 25205619) to the forms table, research notes and safety text. Added a pregnancy FAQ. MSKCC About Herbs has no phellodendron page; LactMed has no record. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| Interactions | Added a warfarin interaction entry from a 2024 review of herb–warfarin interactions (plasma-protein binding). PMID checked with NCBI esummary; wording kept to the abstract. | Writer: Kymata Health EditorialTrigger: Update |
| all | Initial editorial evidence review. Every PMID checked against NCBI E-utilities esummary (title and year) and each cited abstract read; numbers taken from the abstracts (and, where noted, the full text for funding and participant counts). Industry funding disclosed: every trial was funded by Next Pharmaceuticals (Relora and NP 06-1 maker). No agency source covers phellodendron, so safety text cites NCCIH's Using Dietary Supplements Wisely. Where to buy: NOW Foods Relora 300 mg (product page and label checked 2026-10-15). | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.
